Generics Industry News Search
 |
|
|
|
|
|
|
September 2005 News Archive |
|
|
| |
|
Par Pharmaceutical Cos. said Thursday that its licensing partner Amide Pharmaceutical Inc. received Food and Drug Administration approval to market a generic version of Remeron®, an anti-depressant made by Akzo Nobel unit Organon International Inc....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Pharmaceuticals, Inc. today announced that Barr Laboratories, Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its generic versions of Aventis Pharmaceuticals' Allegra(R) (Fexofenadine Hydrochloride) Tablets, 30 mg, 60 mg and 180 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Alpharma Inc., a leading global generic pharmaceutical company, today announced the launch of halobetasol propionate ointment, 0.05%. Alpharma’s halobetasol propionate ointment, which will be available...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ivax Pharmaceuticals is distributing 11 strengths of levothyroxine sodium tablets in the US under an exclusive licensing agreement to use another company’s recently approved abbreviated new drug application (ANDA)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IMPAX Laboratories, Inc. today announced that Alza Corporation and McNeil-PPC, Inc. have filed a complaint against the Company in the United States District Court for the District of Delaware, alleging patent infringement related ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration (FDA) announced the tentative approval of zidovudine oral solution manufactured by Aurobindo Pharma LTD....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sepracor Inc. said a company is trying to make a generic version of its best-selling product, the asthma treatment Xopenex, and pledged to file a lawsuit to block the potential competition....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma major Lupin Ltd Tuesday said it has got approval from the US FDA of its Abbreviated New Drug Application (ANDA) for Lisinopril Tablets. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz, a unit of Swiss drugmaker Novartis, on Tuesday said it sued the U.S. Food and Drug Administration, seeking to force the agency to make a decision on its application to sell a generic human growth hormone....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it has commenced marketing Sulfamethoxazole with Trimethoprim single strength (SS) and double strength (DS) tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Metformin Hydrochloride...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The FDA has granted several generics companies approval to market generic formulations of Sanofi-Aventis' disease-modifying rheumatoid arthritis drug (DMARD) Arava®. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Zentiva N.V. announced today the signing of an agreement for the acquisition of 51% of S.C. Sicomed S.A., the number 1 generics company in Romania via the acquisition of Venoma Holdings Limited for US$102 million in cash. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced the launch of a combination drug product Esterified Estrogens with Methyltestosterone tablets in full and half strengths. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fougera, a specialty manufacturer of dermatologic and ophthalmic pharmaceuticals, announced today that it has received tentative FDA approval to introduce the first generic version of Metronidazole Topical Gel USP 0.75%....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc. a manufacturer of generic pharmaceuticals, today announced that it has commenced marketing Clindamycin capsules 75, 150 and 300 milligrams. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration, Office of Generic Drugs, to manufacture and market Gabapentin Tablets, 600 and 800 mg strengths. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company’s ANDA for Ribavirin Tablets, 200 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Spear Pharmaceuticals is very pleased to announce the approval of Tretinoin Cream USP, .05% (Emollient) effective September 15, 2005. The Spear product is therapeutically equivalent to Johnson & Johnson Consumer Companies,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Pharmaceuticals, Inc. today confirmed that Aventis Pharmaceuticals, Inc. along with Albany Molecular Research, Inc. have filed a motion for a preliminary injunction or expedited trial in the United States District Court for the District of New Jersey. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Taro Pharmaceutical Industries Ltd. reported today that Taro Pharmaceuticals U.S.A., Inc. has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Mupirocin Ointment USP, 2% (mupirocin ointment)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A ruling by Judge Ronald Guzman of the U.S. District Court for the Northern District of Illinois concluded an Abbott Laboratories patent related to sevoflurane combined with water was not infringed by Baxter's generic version of sevoflurane...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SICOR Pharmaceuticals Sales, Inc. is pleased to announce the introduction and availability of Pamidronate Disodium Injection. This product has the same therapeutic effect as Aredia®* for Intravenous Infusion....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Nabi Biopharmaceuticals announced today that it has filed a lawsuit against Roxane Laboratories, Inc. for infringement of its PhosLo® (calcium acetate) gelcap patent. The lawsuit was filed in the United States District Court for the Southern District of Ohio....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Spectrum Pharmaceuticals, today announced that today that it has received approval from the Office of Generic Drugs of the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) for fluconazole tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Noven Pharmaceuticals, Inc., today announced that the U.S. Food & Drug Administration (“FDA”) has advised Noven that the FDA does not expect to approve Noven’s Abbreviated New Drug Application (ANDA) ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IMPAX Laboratories, Inc. announced that it has prevailed in its defense of a lawsuit brought by Alza Corporation, a Johnson & Johnson unit, alleging patent infringement related to IMPAX's filing of an Abbreviated New Drug Application...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited (RLL) announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 120 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis Group, the international generic pharmaceutical company, today announces that it has acquired the generic business of the Hungarian pharmaceutical company, KĂ©ri Pharma. Financial details were not disclosed....
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
